Immune Responses in Patients Treated With Raltegravir (RAG-1/2)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00785967
Recruitment Status : Withdrawn (Unexpected and severe difficulties in recruitment.)
First Posted : November 5, 2008
Last Update Posted : April 14, 2015
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Chris Tsoukas, McGill University Health Center

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Actual Primary Completion Date : August 2011
  Actual Study Completion Date : August 2011